StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
SAGE Therapeutics (SAGE) sinks nearly 50% as trading resumes following CRL
August 7, 2023 7:12 AM
SAGE Therapeutics (NASDAQ: SAGE) sinks 47 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Momentum Movers
Next Articles
Oppenheimer Reiterates Perform Rating on Sage Therapeutics (SAGE)
August 7, 2023 4:56 PM
Sage, Biogen receive setback despite FDA approval of postpartum depression drug. This is why
August 7, 2023 7:04 AM
SAGE Therapeutics (SAGE) to resume trading at 7:10AM ET
August 7, 2023 6:47 AM
Form 8-K Sage Therapeutics, Inc. For: Aug 07
August 7, 2023 6:46 AM
SAGE Therapeutics (SAGE) Misses Q2 EPS by 13c
August 7, 2023 6:44 AM
Sage Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
August 7, 2023 6:30 AM
SAGE Therapeutics (SAGE), Biogen (BIIB) ZURZUVAETM approved in PPD, receives CRL for MDD
August 7, 2023 6:24 AM
RBC Capital Downgrades Sage Therapeutics (SAGE) to Sector Perform
August 7, 2023 3:10 AM
Oppenheimer Downgrades Sage Therapeutics (SAGE) to Perform
August 7, 2023 2:22 AM
Sage Therapeutics to Host Business Update Webcast and Announce Second Quarter Financial Results on Monday, August 7, 2023
August 4, 2023 10:45 PM
